Sitemap
-
Overview and General Administration Guide
-
5.1 Coagulation Factors
-
5.1.1 BIOSTATE (Factor VIII)
-
5.1.2 PROTHROMBINEX-VF (Factors II, IX and X)
-
5.1.3 FEIBA NF (Factor VIII inhibitor bypassing fraction)
-
5.1.4 RiaSTAP (Fibrinogen)
-
5.1.5 FIBROGAMMIN (Factor XIII)
-
5.2 Natural Inhibitors of Coagulation
-
5.2.1 KYBERNIN P
-
5.3 Albumin Solutions
-
5.3.1 ALBUREX® 5 NZ (Human albumin 5%)
-
5.3.2 ALBUMEX 4 (Human albumin 4%)
-
5.3.3 ALBUREX 20 NZ (Human albumin 20%)
-
5.3.4 ALBUMEX 20 (Human albumin 20%)
-
5.4.1 NORMAL IMMUNOGLOBULIN-VF
-
5.4.2 HEPATITIS B IMMUNOGLOBULIN-VF
-
5.4 Immunoglobulin Preparations
-
5.4.3 HyperHEP B
-
5.4.4 TETANUS IMMUNOGLOBULIN-VF
-
5.4.5 TETAGAM P
-
5.4.6 ZOSTER IMMUNOGLOBULIN-VF
-
5.4.7 BERIRAB P (Rabies Immunoglobulin)
-
5.4.8 Rh(D) Immunoglobulin-VF (Anti-D immunoglobulin)
-
5.4.9 RHOPHYLAC (Anti-D immunoglobulin)
-
5.4.10 INTRAGAM P (Human Normal Immunoglobulin 6%)
-
5.4.11 PRIVIGEN NZ / PRIVIGEN (Normal Immunoglobulin) 10% intravenous immunoglobulin (IVIg)
-
5.4.12 GAMUNEX 10%
-
5.4.13 HIZENTRA NZ / HIZENTRA
-
5.5 Other Products
-
5.5.1 BERINERT (C1-esterase inhibitor)
-
5.5.2 BERINERT SC (C1-esterase inhibitor; subcutaneous administration)
-
5.6 Products from Australian Lifeblood (ARC Lifeblood)
-
References